What are the most important infectious diseases among those ≥65 years: A comprehensive analysis on notifiable diseases, Norway, 1993-2011

BMC Infectious Diseases

Volumn 14, Issue 1, 2014, Pages

  Steens, Anneke ^a,b   Eriksen, Hanne Merete ^a   Blystad, Hans ^a  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^b EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CAMPYLOBACTER INFECTIONS; COMMUNICABLE DISEASES; DISEASE NOTIFICATION; FEMALE; HUMANS; MALE; MIDDLE AGED; NORWAY; STAPHYLOCOCCAL INFECTIONS; WHOOPING COUGH; YOUNG ADULT;

EID: 84893164380     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-14-57     Document Type: Article

References (42)

1. Statistics Norway An aging society. 2009, http://www.ssb.no/norge_en/bef_en.pdf, Statistics Norway.
2. Gavazzi G, Krause KH. Ageing and infection. Lancet Infect Dis 2002, 2:659-666. 10.1016/S1473-3099(02)00437-1, 12409046.
3. Liang SY, Mackowiak PA. Infections in the elderly. Clin Geriatr Med 2007, 23:441-456. vii, 10.1016/j.cger.2007.01.010, 17462528.
4. Yoshikawa TT. Epidemiology and unique aspects of aging and infectious diseases. Clin Infect Dis 2000, 30:931-933. 10.1086/313792, 10880303.
5. Juthani-Mehta M, Quagliarello VJ. Infectious diseases in the nursing home setting: challenges and opportunities for clinical investigation. Clin Infect Dis 2010, 51:931-936. 10.1086/656411, 3083824, 20822459.
6. Nicolle LE, Strausbaugh LJ, Garibaldi RA. Infections and antibiotic resistance in nursing homes. Clin Microbiol Rev 1996, 9:1-17. 172878, 8665472.
7. Norwegian Institute of Public Health Causes of death from 1951-2004 [In Norwegian]. 2012, http://www.fhi.no/tema/dodsaarsaker-oglevealder/dodsaarsaker-1951-2004, Norwegian Institute of Public Health.
8. Jefferson T, Di Pietrantonj C, Al Ansary LA, Ferroni E, Thorning S, Thomas RE. Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev 2010, 2:CD004876.
9. Nicolle LE. Urinary tract infection in long-term-care facility residents. Clin Infect Dis 2000, 31:757-761. 10.1086/313996, 11017826.
10. Choi C. Bacterial meningitis in aging adults. Clin Infect Dis 2001, 33:1380-1385. 10.1086/322688, 11550119.
11. Edwards MS, Baker CJ. Group B streptococcal infections in elderly adults. Clin Infect Dis 2005, 41:839-847. 10.1086/432804, 16107984.
12. Kirk MD, Gregory J, Lalor K, Hall GV, Becker N. Foodborne and waterborne infections in elderly community and long-term care facility residents, Victoria, Autralia. Emerg Infect Dis 2012, 18:377-384. 10.3201/eid1803.110311, 3309568, 22377177.
13. Chami K, Gavazzi G, Carrat F, de Wazières B, Lejeune B, Piette F, Rothan-Tondeur M. Burden of infections among 44,869 elderly in nursing homes: a cross-sectional cluster nationwide survey. J Hosp Infect 2011, 79:254-259. 10.1016/j.jhin.2011.08.003, 21899920.
14. Norwegian Surveillance System for Communicable Diseases (MSIS). http://www.msis.no/.
15. Statistics Norway Population at 1st of January in 1990 up to 2011. 2011, http://www.ssb.no/a/aarbok/tab/tab-048.html, Statistics Norway.
16. Nonparametric test for trend across ordered groups. http://www.stata.com/manuals13/rnptrend.pdf.
17. Elstrøm P, Kacelnik O, Bruun T, Iversen B, Hauge SH, Aavitsland P. Meticillin-resistant Staphylococcus aureus in Norway, a low-incidence country, 2006-2010. J Hosp Infect 2012, 80:36-40. 10.1016/j.jhin.2011.10.004, 22118858.
18. European Centre for Disease Prevention and Control Current and future burden of communicable diseases in the European Union and EEA/EFTA countries - Methodology protocol. http://www.ecdc.europa.eu/en/publications/publications/1106_ter_burden_of_disease.pdf, European Centre for Disease Prevention and Control.
19. Health statistics and health information systems. Global burden of disease (GBD) 2001 estimates. http://www.who.int/healthinfo/global_burden_disease/estimates_regional_2001/en/.
20. High KP, Bradley SF, Gravenstein S, Mehr DR, Quagliarello VJ, Richards C, Yoshikawa TT. Clinical practice guideline for the evaluation of fever and infection in older adult residents of long-term care facilities: 2008 update by the Infectious Diseases Society of America. J Am Geriatr Soc 2009, 57:375-394. 10.1111/j.1532-5415.2009.02175.x, 19278394.
21. European Centre of Disease Prevention and Control Annual epidemiological report on communicable diseases in Europe. 2010, http://www.ecdc.europa.eu/en/publications/Publications/1011_SUR_Annual_Epidemiological_Report_on_Communicable_Diseases_in_Europe.pdf, European Centre of Disease Prevention and Control.
22. Dworkin MS, Park L, Borchardt SM. The changing epidemiology of invasive Haemophilus influenzae disease, especially in persons > or = 65 years old. Clin Infect Dis 2007, 44:810-816. 10.1086/511861, 17304452.
23. Rubach MP, Bender JM, Mottice S, Hanson K, Weng HY, Korgenski K, Daly JA, Pavia AT. Increasing incidence of invasive Haemophilus influenzae disease in adults, Utah, USA. Emerg Infect Dis 2011, 17:1645-1650. 10.3201/eid1709.101991, 3322072, 21888789.
24. Lambertsen L, Ekelund K, Skovsted IC, Liboriussen A, Slotved HC. Characterisation of invasive group B streptococci from adults in Denmark 1999 to 2004. Eur J Clin Microbiol Infect Dis 2010, 29:1071-1077. 10.1007/s10096-010-0941-z, 20676713.
25. Castle SC. Clinical relevance of age-related immune dysfunction. Clin Infect Dis 2000, 31:578-585. 10.1086/313947, 10987724.
26. Wester AL, Dunlop O, Melby KK, Dahle UR, Wyller TB. Age-related differences in symptoms, diagnosis and prognosis of bacteremia. BMC Infect Dis 2013, 13:346. 10.1186/1471-2334-13-346, 3733624, 23883345.
27. Pneumovax® 23 (pneumococcal vaccine polyvalent). http://www.merck.com/product/usa/pi_circulars/p/pneumovax_23/pneumovax_pi.pdf.
28. Palacios G, Hornig M, Cisterna D, Savji N, Bussetti AV, Kapoor V, Hui J, Tokarz R, Briese T, Baumeister E, et al. Streptococcus pneumoniae coinfection is correlated with the severity of H1N1 pandemic influenza. PLoS One 2009, 4:e8540. 10.1371/journal.pone.0008540, 2795195, 20046873.
29. O'Brien KL, Walters MI, Sellman J, Quinlisk P, Regnery H, Schwartz B, Dowell SF. Severe pneumococcal pneumonia in previously healthy children: the role of preceding influenza infection. Clin Infect Dis 2000, 30:784-789. 10.1086/313772, 10816149.
30. Mossong J, Hens N, Jit M, Beutels P, Auranen K, Mikolajczyk R, Massari M, Salmaso S, Tomba GS, Wallinga J, et al. Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Med 2008, 5:e74. 10.1371/journal.pmed.0050074, 2270306, 18366252.
31. Statistics Norway Travel survey. https://www.ssb.no/statistikkbanken/SelectVarVal/Define.asp?MainTable=Turer2&KortNavnWeb=reise&PLanguage=0&checked=true, Statistics Norway.
32. Lexau CA, Lynfield R, Danila R, Pilishvili T, Facklam R, Farley MM, Harrison LH, Schaffner W, Reingold A, Bennett NM, et al. Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine. JAMA 2005, 294:2043-2051. 10.1001/jama.294.16.2043, 16249418.
33. Hammitt LL, Bruden DL, Butler JC, Baggett HC, Hurlburt DA, Reasonover A, Hennessy TW. Indirect effect of conjugate vaccine on adult carriage of Streptococcus pneumoniae: an explanation of trends in invasive pneumococcal disease. J Infect Dis 2006, 193:1487-1494. 10.1086/503805, 16652275.
34. Miller E, Andrews NJ, Waight PA, Slack MP, George RC. Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study. Lancet Infect Dis 2011, 11:760-768. 10.1016/S1473-3099(11)70090-1, 21621466.
35. Steens A, Bergsaker MA, Aaberge IS, Rønning K, Vestrheim DF. Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway. Vaccine 2013, 13:6232-6238.
36. EUvac.net Pertussis surveillance report 2010. 2011, http://www.ecdc.europa.eu/en/publications/Publications/pertussis_report_2010_euvacnet.pdf, EUvac.net.
37. Kalenic S, Cookson B, Gallagher R, Popp W, Asensio-Vegas A, Assadian O, Blok O, Brussafero S, Eastaway A, Elstrom P, et al. Comparison of recommendations in national/regional Guidelines for prevention and control of MRSA in thirteen European countries. Int J Infection Control 2010, 6. doi:10.3396/ijic.V6i2.016.10.
38. Moxnes JF, de Blasio BF, Leegaard TM, Moen AE. Methicillin-resistant Staphylococcus aureus (MRSA) is increasing in Norway: a time series analysis of reported MRSA and methicillin-sensitive S. aureus cases, 1997-2010. PLoS One 2013, 8:e70499. 10.1371/journal.pone.0070499, 3731260, 23936442.
39. Kacelnik O. Ward based cohort study of the first reported outbreak of Vancomycin resistant enterococci in a Norwegian hospital [abstract]. Eur Sci Conference Appl Infectious Disease Epidemiology 2012, Abstract number 2012663.
40. Guzman-Herrador B, Vold L, Nygård K. Surveillance of travel-associated gastrointestinal ionfections in Norway, 2009-2010: are they actually imported?. Eurosurveillance 2012, 17(41). http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20294.
41. Heldal E, Docker H, Caugant DA, Tverdal A. Pulmonary tuberculosis in Norwegian patients. The role of reactivation, re-infection and primary infection assessed by previous mass screening data and restriction fragment length polymorphism analysis. Int J Tuberc Lung Dis 2000, 4:300-307.
42. Michel JP. Updated vaccine guidelines for aging and aged citizens of Europe. Expert Rev Vaccines 2010, 9:7-10. 10.1586/erv.10.27, 20192711.